TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Grey Wolf Animal Health Corp ( (TSE:WOLF) ) is now available.
Grey Wolf Animal Health Corp reported an 8.6% increase in fourth-quarter revenue to $6.7 million and a 5.6% increase for the full year to $26.8 million, driven by organic growth and the acquisition of The Compounding Pharmacy of Manitoba. The acquisition is expected to enhance their Pharmacy business and strengthen their market position. Despite a decline in commission revenues, the Animal Health business saw a 1.9% growth due to new and established products. The company’s gross profit and adjusted EBITDA also saw significant improvements, indicating strong operational performance.
More about Grey Wolf Animal Health Corp
Grey Wolf Animal Health Corp is a Canadian diversified health company that operates in the animal health industry. The company focuses on providing compounded animal health products and has a presence in the compounded human health product market as well.
YTD Price Performance: -16.81%
Average Trading Volume: 14,293
Technical Sentiment Signal: Hold
Current Market Cap: C$32.48M
For detailed information about WOLF stock, go to TipRanks’ Stock Analysis page.